Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2005
08/11/2005CA2554489A1 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
08/11/2005CA2554455A1 Anorectic
08/11/2005CA2554185A1 Neuroprotective complex for treatment of cerebral ischemia and injury
08/11/2005CA2553931A1 Erythrocyte function modifying substance
08/11/2005CA2553866A1 Treatment of degenerative cartilage conditions in a mammal with glycosi dase inhibitors
08/11/2005CA2553775A1 Compositions and methods of treatment for inflammatory diseases
08/11/2005CA2553455A1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
08/11/2005CA2553390A1 Vaginal compositions for treating infections
08/10/2005EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/10/2005EP1561472A1 Solid preparation
08/10/2005EP1561467A1 Composition for restoring damaged skin
08/10/2005EP1561466A2 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis
08/10/2005EP1561458A1 Rapidly disintegrable solid preparation
08/10/2005EP1560598A1 Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity
08/10/2005EP1560596A1 Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics
08/10/2005EP1560591A2 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
08/10/2005EP1560587A1 Cholesterol efflux and uses thereof
08/10/2005EP1560582A2 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE
08/10/2005EP1560579A1 Cholesterol absorption inhibitors for the treatment of autoimmune disorders
08/10/2005EP1471919B1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/10/2005EP1299114B1 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
08/10/2005EP1210092A4 Calcium-containing structures and methods of making and using the same
08/10/2005EP0927036B9 Transdermal therapeutical approach involving a combination of bisphosphate containing oestriol
08/10/2005EP0894009B1 Improved vision through photodynamic therapy of the eye
08/10/2005EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
08/10/2005CN1653075A C-aryl glucoside SGLT2 inhibitors and method
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652844A Combination of a CDK inhibitor and 5-FU for the treatment of cancer
08/10/2005CN1652842A 3'- (2z)- 1-(3, 4-dimethylphenyl)-1, 5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy- 1, 1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
08/10/2005CN1652822A New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
08/10/2005CN1652821A Human monoclonal antibodies to prostate specific membrane antigen (PSMA)
08/10/2005CN1652814A Induction of antigen specific immunologic tolerance
08/10/2005CN1652812A Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
08/10/2005CN1652811A A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
08/10/2005CN1652810A Immunosuppressant compounds, methods and uses related thereto
08/10/2005CN1652800A Remedies for lung cancer
08/10/2005CN1652798A Continuous sulfatase inhibiting progestogen hormone replacement therapy
08/10/2005CN1652795A Compositions and methods for treating emphysema
08/10/2005CN1652791A Synergistic enhancement of cognitive ability
08/10/2005CN1652788A Method of treating diabetes
08/10/2005CN1652787A Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
08/10/2005CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/10/2005CN1652785A Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652778A Method for treating obesity
08/10/2005CN1652777A Combination of organic compounds
08/10/2005CN1652774A Use of valsartan or its metabolite to inhibit platelet aggregation
08/10/2005CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof
08/10/2005CN1652770A Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
08/10/2005CN1652767A Adduct of topiramate and tramadol hydrochloride and uses thereof
08/10/2005CN1652761A Preventive or therapeutic agent for kidney disease
08/10/2005CN1652757A Use of EDG receptor binding agents in cancer
08/10/2005CN1652749A Co-grinding process for the preparation of a ternary composition
08/10/2005CN1652698A Method and dietary composition for improving lipid digestibility
08/10/2005CN1652697A Method and dietary composition for improving fat digestibility
08/10/2005CN1652696A Method of improving absorption of vitamin E by a pet animal
08/10/2005CN1652695A Method of improving growth performance of animal
08/10/2005CN1651090A Transmission system of medicine containing trehalose and hyaluronic acid for eye part and its preparation method
08/10/2005CN1651087A Combination of organic compounds
08/10/2005CN1651086A Compound red yeast extract medicinal preparation and its application
08/10/2005CN1651085A Compound aspirin tading kind medicinal preparation and its application
08/10/2005CN1651084A Injection liquid for eliminating skin umbilication defect and its preparation method
08/10/2005CN1651074A Use of neurotoxin therapy for treatment of urologic and related disorders
08/10/2005CN1651071A CD154 blockade therapy for therapeutic protein inhibitor syndrome
08/10/2005CN1650872A Externally used medicine for treating sexual dysfunction
08/10/2005CN1650868A Compound medicinal preparation for treating pneumonia infection disease and its preparation method
08/10/2005CN1650863A Antibiotic compositions for treatment of the eye, ear and nose
08/10/2005CN1650856A Sensitizing energistic agent of chemotherapy medicine for treating tumour
08/10/2005CN1214059C Aqueous dispersion body of water insoluble organic ultraviolet ray filtering material
08/10/2005CN1213757C Combinations for treatment of DNA viral infections
08/10/2005CN1213753C Composition alleviating pain, containing a non-napcotic and an analgesia enhancer
08/10/2005CN1213752C Treating allergic and inflammatory diseases
08/10/2005CN1213746C Immunopotentiatory agents and physiologically acceptable salts thereof
08/10/2005CN1213742C Pharmaceutical control of inflammation
08/10/2005CN1213724C Local compsn. contg. tocopherol
08/10/2005CN1213659C Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and composition containing the same
08/09/2005US6927317 Modulating ramp activity
08/09/2005US6927235 Vaccine composition comprising iron phosphate as vaccine adjuvant
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/09/2005US6927211 Method for reducing toxicity of combined chemotherapies
08/09/2005US6927206 treating dermatological conditions related to rosacea by topically applying a composition comprising at least one peptide copper complex to an area of affected skin
08/09/2005US6927054 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects
08/09/2005US6926912 Metal compounds, mixed or sulphated, as phosphate binders
08/09/2005US6926907 Pharmaceutical compositions for the coordinated delivery of NSAIDs
08/09/2005CA2231700C Prodrugs of aspartyl protease inhibitors
08/09/2005CA2178603C Transdermal therapeutical system for preventing poisoning by organophosphoric neurotoxins that consists of a combination of active substances including a parasympathomimetric and a parasympatholytic agent
08/09/2005CA2168012C Polymeric matrices and their uses in pharmaceutical compositions
08/09/2005CA2136952C Preparation for activation of natural killer cells (nk-cells), said preparation containing interferon-– and histamine, serotonin, amines or substances with corresponding receptor activity
08/04/2005WO2005071409A1 Remedy for pancreatic cancer
08/04/2005WO2005071098A1 Method of screening substance improving lipid metabolism
08/04/2005WO2005071093A2 Chimpanzee adenovirus vaccine carriers
08/04/2005WO2005070874A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/04/2005WO2005070868A1 Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
08/04/2005WO2005070469A1 Methods of treating mesothelioma using an antisense oligonucleotide to thymidylate synthase
08/04/2005WO2005070463A2 Compositions comprising (s)-amlodipine malate and an angiotensin receptor blocker and methods of their use
08/04/2005WO2005070462A2 Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use
1 ... 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 ... 1151